Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4639711
[patent_doc_number] => 08017738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Hemopoietin receptor protein, NR10'
[patent_app_type] => utility
[patent_app_number] => 11/980135
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23142
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11980135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/980135 | Hemopoietin receptor protein, NR10 | Oct 29, 2007 | Issued |
Array
(
[id] => 6426602
[patent_doc_number] => 20100151566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'RECOMBINANT ANTIBODIES AGAINST THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)'
[patent_app_type] => utility
[patent_app_number] => 12/447711
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19561
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12447711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/447711 | RECOMBINANT ANTIBODIES AGAINST THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5356652
[patent_doc_number] => 20090187996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Ion Channel'
[patent_app_type] => utility
[patent_app_number] => 11/926693
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31441
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20090187996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11926693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/926693 | Ion Channel | Oct 28, 2007 | Abandoned |
Array
(
[id] => 5495337
[patent_doc_number] => 20090263365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Methods and compositions for transforming dendritic cells and activating cells'
[patent_app_type] => utility
[patent_app_number] => 11/978019
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18354
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978019 | Methods and compositions for transforming dendritic cells and activating cells | Oct 24, 2007 | Abandoned |
Array
(
[id] => 5410050
[patent_doc_number] => 20090123949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'METHODS FOR DETERMINING THE PROGNOSIS FOR CANCER PATIENTS USING TUCAN'
[patent_app_type] => utility
[patent_app_number] => 11/874867
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23999
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874867
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874867 | METHODS FOR DETERMINING THE PROGNOSIS FOR CANCER PATIENTS USING TUCAN | Oct 17, 2007 | Abandoned |
Array
(
[id] => 4733772
[patent_doc_number] => 20080050751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'NONHUMAN MODEL ANIMAL OF TH2-MEDIATED HYPERIMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 11/874048
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9648
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874048 | Nonhuman model animal of Th2-mediated hyperimmune response | Oct 16, 2007 | Issued |
Array
(
[id] => 4513672
[patent_doc_number] => 07910370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Methods of using BCL-2 for the therapeutic treatment and prevention of diseases'
[patent_app_type] => utility
[patent_app_number] => 11/869634
[patent_app_country] => US
[patent_app_date] => 2007-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 13995
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910370.pdf
[firstpage_image] =>[orig_patent_app_number] => 11869634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/869634 | Methods of using BCL-2 for the therapeutic treatment and prevention of diseases | Oct 8, 2007 | Issued |
Array
(
[id] => 5403525
[patent_doc_number] => 20090238839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Somatic Transgene Immunization and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 11/869463
[patent_app_country] => US
[patent_app_date] => 2007-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 34420
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11869463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/869463 | Somatic Transgene Immunization and Related Methods | Oct 8, 2007 | Abandoned |
Array
(
[id] => 4745272
[patent_doc_number] => 20080089874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'DIRECTED DIFFERENTIATION AND MATURATION OF STEM CELL-DERIVED CARDIOMYOCYTES'
[patent_app_type] => utility
[patent_app_number] => 11/864755
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30435
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089874.pdf
[firstpage_image] =>[orig_patent_app_number] => 11864755
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/864755 | DIRECTED DIFFERENTIATION AND MATURATION OF STEM CELL-DERIVED CARDIOMYOCYTES | Sep 27, 2007 | Abandoned |
Array
(
[id] => 4802588
[patent_doc_number] => 20080014175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Methods and Compositions for Viral Enhancement of Cell Killing'
[patent_app_type] => utility
[patent_app_number] => 11/863173
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11139
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11863173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/863173 | Methods and Compositions for Viral Enhancement of Cell Killing | Sep 26, 2007 | Abandoned |
Array
(
[id] => 5560303
[patent_doc_number] => 20090271880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'BINDING MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/441581
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11959
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20090271880.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441581 | BINDING MOLECULES | Sep 17, 2007 | Abandoned |
Array
(
[id] => 6614541
[patent_doc_number] => 20100132055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'ANIMAL MODEL FOR THE SELECTION AND VALIDATION OF AGENTS ACTIVE AGAINST PULMONARY EMPHYSEMA AND COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/441235
[patent_app_country] => US
[patent_app_date] => 2007-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8126
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20100132055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441235 | ANIMAL MODEL FOR THE SELECTION AND VALIDATION OF AGENTS ACTIVE AGAINST PULMONARY EMPHYSEMA AND COLORECTAL CANCER | Sep 3, 2007 | Abandoned |
Array
(
[id] => 6430419
[patent_doc_number] => 20100143315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/439431
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11295
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143315.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439431
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439431 | Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scARC) through murinization thereof | Aug 30, 2007 | Issued |
Array
(
[id] => 4675625
[patent_doc_number] => 20080213254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Bispecific molecules cross-linking ITIM and ITAM for therapy'
[patent_app_type] => utility
[patent_app_number] => 12/001454
[patent_app_country] => US
[patent_app_date] => 2007-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4136
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001454 | Bispecific molecules cross-linking ITIM and ITAM for therapy | Aug 27, 2007 | Abandoned |
Array
(
[id] => 4669405
[patent_doc_number] => 20080044465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'THERAPY FOR CELLULAR ACCUMULATION IN CHRONIC INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/846351
[patent_app_country] => US
[patent_app_date] => 2007-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15424
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11846351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/846351 | THERAPY FOR CELLULAR ACCUMULATION IN CHRONIC INFLAMMATORY DISEASES | Aug 27, 2007 | Abandoned |
Array
(
[id] => 4917889
[patent_doc_number] => 20080098490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Transgenic mammals having human Ig loci including plural Vh and Vk regions and antibodies produced therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/894779
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 20116
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20080098490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894779 | Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom | Aug 19, 2007 | Issued |
Array
(
[id] => 4731305
[patent_doc_number] => 20080209580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Mouse developing visceral fat type obesity and diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/889593
[patent_app_country] => US
[patent_app_date] => 2007-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 6443
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20080209580.pdf
[firstpage_image] =>[orig_patent_app_number] => 11889593
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/889593 | Mouse developing visceral fat type obesity and diabetes | Aug 14, 2007 | Issued |
Array
(
[id] => 111543
[patent_doc_number] => 07718427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Established cell lines from Lymantria xylina '
[patent_app_type] => utility
[patent_app_number] => 11/839500
[patent_app_country] => US
[patent_app_date] => 2007-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5071
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11839500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/839500 | Established cell lines from Lymantria xylina | Aug 14, 2007 | Issued |
Array
(
[id] => 4808135
[patent_doc_number] => 20080171713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/836640
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3990
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11836640
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/836640 | SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES | Aug 8, 2007 | Abandoned |
Array
(
[id] => 196815
[patent_doc_number] => 07638498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Substances for preventing and treating autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 11/836661
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4005
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11836661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/836661 | Substances for preventing and treating autoimmune diseases | Aug 8, 2007 | Issued |